Influenza activity is surging across the western United States weeks ahead of its usual timetable, prompting infectious disease specialists to encourage early vaccinations against seasonal respiratory bugs.
While annual flu transmissions traditionally begin accelerating in October or November, healthcare providers observed positive test numbers and emergency room visits climbing as early as September. The geographical footprint has also defied historical trends: transmissions usually originate across southern states, but this season began concentrating in Western regions including California, Washington, Hawaii and Alaska, NPR reported.
Unusual timing and mutated variant
Specialists say the early transmission curve mirrors numbers that hospitals normally do not encounter until deep into the winter. Caitlin Rivers, an epidemiologist with the Johns Hopkins Bloomberg School of Public Health, told NPR that while nationwide numbers remain relatively low, early activity in the West reflects levels typically seen closer to December.
Scientists point to viral evolution as a leading factor behind the unseasonal transmission wave. Dr. Alex Greninger, who directs infectious disease diagnostics at the University of Washington, told NPR that medical facilities in his area are encountering flu levels comparable to late December. He noted that a newly detected mutated variant appears more capable of bypassing pre-existing immune defenses, notably among teenagers.
Given the variant’s spread, virologists including Scott Hensley of the University of Pennsylvania are telling people not to delay seasonal shots, according to NPR.
Vaccine choices and high-risk patients
All seasonal influenza immunizations this year are trivalent formulations engineered to protect against three separate virus strains, WJAR reported. Because developing protective antibodies requires approximately two weeks following an injection, medical professionals advise getting vaccinated before broad community transmission accelerates, according to WXYZ-TV.
Federal guidelines recommend annual flu shots for virtually everyone aged six months and older, WXYZ reported. Special formulations exist for specific groups, including high-dose and adjuvanted shots tailored to generate stronger antibody responses in adults aged 65 and older, as well as nasal spray options for non-pregnant individuals between ages two and 49, according to WJAR.
Dr. Charelle Allen, a primary care physician with Brown University Health, told WJAR that older adults, young children and patients managing chronic conditions such as diabetes, heart disease, asthma and chronic obstructive pulmonary disease face the greatest vulnerability to serious respiratory complications.
Broader viral season and CDC response
The influenza spike arrives as medical providers also prepare for circulating COVID-19 and respiratory syncytial virus, or RSV. The Centers for Disease Control and Prevention’s annual outlook projected that peak hospital admissions across all three respiratory ailments will likely match figures from last year, according to WXYZ.
Eligible Americans can safely receive updated COVID-19 shots alongside their flu vaccines during the same appointment, WXYZ reported. RSV immunization is also recommended for seniors aged 75 and older, vulnerable adults aged 50 to 74 with underlying conditions, and expectant mothers between weeks 32 and 36 of pregnancy to shield newborns, according to both WJAR and WXYZ.
The early outbreak comes amid shifts at the federal level. NPR reported that the CDC has not conducted its usual promotional push for flu shots under Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine skeptic. Dr. Demetre Daskalakis, who previously directed the CDC’s National Center for Immunization and Respiratory Diseases, told NPR that federal silence is troubling given that the flu regularly causes tens of thousands of hospitalizations.
The agency declined an interview request but stated to NPR that it is crafting an updated communications strategy intended to outline vaccine benefits and risks while providing information to guide public decision-making.
